Evaluating treatment strategies for non-small cell lung cancer during COVID-19: A propensity score matching analysis.

ABSTRACT: We employed pandemic treatment strategies that we developed at the beginning of the coronavirus disease 2019 (COVID-19) pandemic, and it was not clear whether any adverse results were associated with our strategies. Therefore, we carried out a retrospective study to compare our pandemic treatment strategies with prepandemic protocols to determine whether the strategies used during the high-risk period of COVID-19 were appropriate. The observation period was September 2019 to February 2020. Patients hospitalized from December 2019 to February 2020 were included as an experimental group, and individuals hospitalized from September 2019 to November 2019 were included as a control group. All non-small cell lung cancer patients hospitalized during the observation period were included except for

SUBMITTER: Yu M 

PROVIDER: S-EPMC9370248 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature